Q1 2025 Tecsys Inc Earnings Call Transcript
Key Points
- Tecsys Inc (TCYSF) reported a strong start to fiscal 2025 with a 33% year-over-year increase in SaaS revenue and a 57% increase in SaaS bookings.
- The company secured a major healthcare migration deal with one of the largest IDNs in North America, highlighting significant growth potential.
- Tecsys Inc (TCYSF) continues to experience traction in the pharmacy supply chain, with a growing interest in their centralized pharmacy service center model.
- The company has a robust backlog and a strong balance sheet with $27.1 million in cash and no debt, supporting its growth initiatives.
- Tecsys Inc (TCYSF) is expanding its partner ecosystem, with about a third of its deals being partner-influenced over the last 12 months, enhancing market access and product development.
- Total revenue growth was only 1% compared to the same period last year, with fluctuations in professional services and hardware revenue affecting overall growth.
- Professional services revenue decreased by 10% year-over-year, impacted by project delivery schedules outside of the company's control.
- Net profit for the quarter decreased by $400,000 to $798,000 compared to the same quarter last year.
- Adjusted EBITDA was down to $2.6 million from $3.2 million in the same period last year.
- The company faces challenges in the timing of SaaS revenue recognition, with some deals having delayed starts, affecting immediate revenue realization.
Good morning, everyone. Welcome to Tecsys first quarter fiscal year 2025 results conference call.
Please note that the complete first quarter report, including MD&A and financial statements, were filed on SEDAR+ after market close yesterday. All dollar amounts are expressed in Canadian currency and are prepared in accordance with International Financial Reporting Standards. The company has added a companion presentation to today's call, which is available on our website at www.texas.com/investors.
Some of the statements in this conference call, including the question-and-answer period, may include forward-looking statements that are based on management's beliefs and assumptions. Actual results may differ materially from such statements. I would like to remind everyone that this call is being recorded on Friday, September 6, 2024, at 8:30 AM Eastern Time.
I would now like to turn the conference over to Mr. Peter Brereton, Chief Executive Officer at Tecsys. Please go ahead, sir.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |